Table 3.
Proportion of Admissions for Vascular Events Attributed to a Given Viral Infection for All Weeks in the Study Period, and Restricted to Weeks With High (>90th Percentile) Counts of Infection
| Outcome | Age Group, ya | Virus | Proportion of Vascular Events Attributed to Infection | |||
|---|---|---|---|---|---|---|
| 2004–2015 | 2010–2015 | |||||
| All Weeks | Weeks With High Counts of Infection | All Weeks | Weeks With High Counts of Infection | |||
| MI admissions | ≥75 | Influenza | 0.4% | 2.8% | 0.7% | 4.3% |
| RSV | 1.6% | 7.6% | 2.0% | 9.2% | ||
| Adenovirus | 2.6% | 6.6% | 5.7% | 11.6% | ||
| Rhinovirus | 2.6% | 7.6% | 5.0% | 9.6% | ||
| HMPVb | … | … | 3.0% | 9.2% | ||
| 65–74 | Adenovirus | 2.6% | 6.5% | 5.3% | 10.7% | |
| Rhinovirus | 2.0% | 6.3% | 3.1% | 5.8% | ||
| RSV | 1.4% | 6.9% | 1.7% | 7.8% | ||
| All stroke admissions | ≥75 | RSV | 0.7% | 3.5% | 0.9% | 4.1% |
| HMPVb | … | … | 1.7% | 5.4% | ||
| Ischemic stroke admissions | ≥75 | Influenza | 0.4% | 2.6% | 0.6% | 3.9% |
| RSV | 1.0% | 4.9% | 1.2% | 5.7% | ||
| Adenovirus | 2.3% | 5.3% | 3.6% | 7.3% | ||
| Rhinovirus | 2.9% | 7.7% | 4.6% | 9.1% | ||
| HMPVb | … | … | 1.3% | 4.2% | ||
Abbreviations: HMPV, human metapneumovirus; MI, myocardial infarction; RSV, respiratory syncytial virus.
aBased on optimal model for each virus.
bData for January 2010 to March 2015.